Raymond Cohen

Raymond Cohen

Direktor/Vorstandsmitglied bei RXSIGHT, INC.

Vermögen: 2 Mio $ am 31.07.2026

67 Jahre
Health Technology
Commercial Services
Finance

Profil

Mr. Raymond W.
Cohen is an Independent Director at RxSight, Inc., an Independent Director at Kestra Medical Technologies Ltd., a Partner at Zhuhai Sherpa Equity Investment Management Co. Ltd., a Chairman at Archimedes Vascular, Inc., a Chairman at BioBeat Technologies Ltd., a Chairman at BiVACOR, Inc., a Chairman at Nalu Medical, Inc., an Independent Director at ECS Opco 1 LLC, a Member at Forum for Corporate Directors and a Venture Advisor at Andera Partners SCA. He is on the Board of Directors at RxSight, Inc., Tulavi Therapeutics, Inc., Kestra Medical Technologies Ltd., BioGenex Laboratories, Inc. and ECS Opco 1 LLC.
Mr. Cohen was previously employed as an Independent Director by InspireMD, Inc., a Chairman by SoniVie Ltd., a Chairman by BioVentrix, Inc., a Chief Executive Officer & Director by Axonics, Inc., an Independent Non-Executive Director by Spectrum Pharmaceuticals, Inc., a Chairman by Lombard Medical, Inc., a Non-Executive Chairman by JenaValve Technology GmbH, a Chief Executive Officer by Boston Scientific Corp., a Chief Executive Officer & Director by Vessix Vascular, Inc., an Independent Director by CardioGenesis Corp., a Chairman by BioLife Solutions, Inc., a Non-Executive Chairman by Syncroness, Inc., a Chairman, President & Chief Executive Officer by Cardiac Science, Inc., a President by Diagnostic Monitoring, a Chairman by DYSIS Medical Ltd., a Chairman by JenaValve Technology, Inc., a Non-Executive Chairman by Lombard Medical Technologies Ltd., a Chairman by LoneStar Heart, Inc., a Member-Biomedical Leadership Council by OCTANe, and a Chief Executive Officer & Director by The Irvine Co. LLC.
He also served on the board at Kestra Medical Technologies, Inc., LifeWatch AG, CardioPolymers, Inc., Cardiac Science Corp., BioTelemetry, Inc. and Nyxoah SA. He received his undergraduate degree from State University of New York at Binghamton.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
0.09%
17.07.2026 50’903 ( 0.09% ) 1 Mio $ 31.07.2026
17.06.2026 66’532 ( 0.16% ) 399 857 $ 31.07.2026
10.04.2026 92’417 ( 0.2% ) 60 071 $ 31.07.2026

Aktive Positionen von Raymond Cohen

UnternehmenPositionBeginn
RXSIGHT, INC. Direktor/Vorstandsmitglied 31.07.2025
Berater -
Private Equity Investor 01.01.2025
Vorsitzender -
Vorsitzender -
Direktor/Vorstandsmitglied 01.06.2025
Direktor/Vorstandsmitglied 01.11.2013

Ehemalige bekannte Positionen von Raymond Cohen

UnternehmenPositionEnde
INSPIREMD, INC. Direktor/Vorstandsmitglied 01.07.2026
Direktor/Vorstandsmitglied 01.01.2025
░░░░░░░ ░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Raymond Cohen im Detail an

Ausbildung von Raymond Cohen

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

65

Beziehungen ersten Grades

36

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen36

Health Technology

Health Technology

Commercial Services

Health Technology

Finance

Health Technology

Health Technology

Electronic Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Consumer Services

Health Technology

Industrial Services

Health Technology

Health Technology

Forum for Corporate Directors

Diagnostic Monitoring

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

  1. Börse
  2. Insiders
  3. Raymond Cohen